Category Archives: News

Enbiosis is attending BioIndustry Association (BIA) Start-Up Festival

Enbiosis is attending BioIndustry Association (BIA) Start-Up Festival

We will be attending BioIndustry Association (BIA)‘s Start-Up Festival on the 25th of May to connect with London’s dynamic start-up community and gain more insights from peers and experts. The event will take place in person for the first time this year, and we are happy to be a part of it. The BioIndustry Association […]

Enbiosis is attending Centuro Global Expansion Conference on May 4th

Enbiosis Centuro Global Expansion Conference

We are thrilled to announce that will be attending the Centuro Global Expansion Conference on May 4th to present our groundbreaking AI technology that provides personalized gut health solutions. Join us for the live tech presentations session, which will begin at 15.05, as we showcase our cutting-edge technology and share insights into the future of […]

Join us at the IFM AIC 2023 for the presentation of our new multicentric IBS study

Enbiosis IFM Annual International Conference 2023

We are thrilled to announce that we will be attending the upcoming IFM Annual International Conference 2023. This year’s theme is ‘Advancements in clinical research and innovative practices in functional medicine’ and Varol Tunalı, our CMO will be presenting the results of our new multicentric IBS study, which is a breakthrough in the field of digestive […]

Enbiosis will attend London Conference Startups from Seoul 2023

Enbiosis London Conference Startups

We will be attending the 2023 London Conference Startups from Seoul, which is hosted by the Seoul Metropolitan Government and organized by Invest Seoul. This event promises to be an amazing opportunity to gain insight into new finance business and investment opportunities in Seoul, South Korea. The event will be graced by the presence of […]

Enbiosis will present clinical trial on IBS AGA Diet and the Gut Microbiome session

AGA Diet and the Gut Microbiome session

We would like to invite you to one of the most prestigious Gastroenterology events in the world. We will be presenting the groundbreaking results of our current clinical trial on IBS on the 8th of May in AGA Diet and the Gut Microbiome session.

Enbiosis has been selected as a finalist in the NutraIngredients Europe Awards

Enbiosis NutraIngredients Europe Awards

We are thrilled to announce that our Personalized Prebiotic and Probiotic Suggestion Engine has been selected as a finalist in the NutraIngredients Europe Awards for the category of Product of the Year: Microbiome Modulation.Our engine is designed to analyze the human gut microbiome and determine the best fit of prebiotics and probiotics for individuals’ needs.

Cookies are placed on our site. For detailed information about cookies, you can review the Terms of Use and Privacy Policy.